Bristol Myers Squibb (BMY) Exchange Rate Effect (2009 - 2026)

Bristol Myers Squibb (BMY) has reported Exchange Rate Effect for 18 consecutive years, with -$10.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Exchange Rate Effect fell 107.81% year-over-year to -$10.0 million in Q2 2026; TTM through Jun 2026 was -$57.0 million, a 145.97% decrease from a year earlier, with the FY2025 full-year figure at $195.0 million, up 242.34% from the prior year.
• Exchange Rate Effect was -$10.0 million for Q2 2026 at Bristol Myers Squibb, up from -$48.0 million in the prior quarter.
• Over five years, Exchange Rate Effect peaked at $128.0 million in Q2 2025 and troughed at -$147.0 million in Q4 2024.
• A 5-year average of $666666.7 and a median of -$6.0 million in 2023 frame the typical range for Exchange Rate Effect.
• Across the five-year window, Exchange Rate Effect tumbled 494.44% in 2022 and soared 681.82% in 2025, its largest moves.
• Over 5 years, Exchange Rate Effect stood at $95.0 million in 2022, then slipped by 17.89% to $78.0 million in 2023, then slumped by 288.46% to -$147.0 million in 2024, then surged by 103.4% to $5.0 million in 2025, then slumped by 300.0% to -$10.0 million in 2026.
• The last three Exchange Rate Effect figures came in at -$10.0 million (Q2 2026), -$48.0 million (Q1 2026), and $5.0 million (Q4 2025), per Business Quant data.